Sign in
4

Changes in Ownership

PROTHENA CORP PUBLIC LTD CO Filed Acc 0001567619-21-004318

Chief Scientific Officer sold 26,310 shares at an average $19.16 ($504,057)

  • Chief Scientific Officer acquired 26,310 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Zago Wagner M. · Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-12 Exercise or conversion : show line 1 in the form +7,560 $6.41 $48,460 7,560 D
2021-02-12 Sale : show line 2 in the form −7,560 $17.07 $129,049 0 D
2021-02-12 Exercise or conversion : show line 3 in the form +18,750 $13.53 $253,688 18,750 D
2021-02-12 Sale : show line 4 in the form −18,750 $20.00 $375,008 0 D
Open-market sales · 26,310 sh · avg $19.16 · $504,057

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-02-12 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −7,560 $6.41 2023-01-29 7,560 7,540 D
2021-02-12 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −18,750 $13.53 2029-02-27 18,750 31,250 D
Loading xslF345X03/doc1.xml…